Hypertrophic Cardiomyopathy

This book provides a comprehensive clinical review of Hypertrophic Cardiomyopathy (HCM), the most common genetic disorder of the heart characterized by dysfunctional contractility at the sarcomere level, resulting in the development of abnormal and occasionally focal hypertrophy on a macroscopic level.

Editor, Srihari S. Naidu, has brought together a world renowned group of experts to review various different topics but, with a practical focus that will enable readers to establish the evidence-based best practice in any potential scenario. Treatment modalities including medications, pacemakers and defibrillators, and invasive septal reduction therapy (both surgical myectomy and alcohol septal ablation) will be discussed. Chapters on genetics, family screening, lifestyle concerns, and athletic screening have additionally been added given the ongoing controversies and differences of opinion on many of these issues. 

Each chapter within Hypertrophic Cardiomyopathy begins with key points of knowledge and ends with clinical pearls that have not previously been disseminated to the wider community. The practical approach of the entire book continues with dedicated chapters on creating a Center of Excellence, including how to facilitate the multi-disciplinary approach, and on case-based reviews and discussions allowing readers to further understand how to integrate the knowledge gained from each chapter into the comprehensive and longitudinal care of the individual patient and family. The last chapter takes the reader through the management of actual patients, showing over decades the nuances to diagnosis and management and the sometimes abrupt changes in the course of their diseases that necessitate correspondingly abrupt modifications in treatment. 

This book will be an essential text for Trainees, Fellows, Residents and board-certified physicians in cardiology, interventional cardiology, cardiac surgery, cardiac imaging, sports medicine, paediatric cardiology, genetics and genetic counselling, and electrophysiology.

Srihari S. Naidu MD, FSCAI, FACC, FAHA, Editor of Hypertrophic Cardiomyopathy is an Associate Professor of Medicine at the State University of New York at Stony Brook School of Medicine, and Director of the Cardiac Catheterization Laboratory, Interventional Cardiology Fellowship Program and Hypertrophic Cardiomyopathy Treatment Center at Winthrop University Hospital in Long Island, New York.   He completed training in internal medicine at New York Presbyterian Hospital - Cornell Medical Center and general and interventional cardiology at the University of Pennsylvania Medical Center.

A recognized expert in the management of patients with Hypertrophic Cardiomyopathy in general, and the minimally-invasive alternative to open heart surgery alcohol septal ablation in particular, Dr. Naidu runs a comprehensive, multi-disciplinary Hypertrophic Cardiomyopathy Center of Excellence managing over 400 patients and families with the disease. The author of over 85 original manuscripts and book chapters, Dr. Naidu lectures regularly throughout the United States on Hypertrophic Cardiomyopathy, Interventional Cardiology, and leadership aspects of achieving career success, and co-runs a live national proctoring course on the alcohol septal ablation technique.

A nationally regarded cardiologist, Dr. Naidu serves on several committees within the American College of Cardiology (ACC), has co-authored or chaired national guidelines and consensus statements, and is a Trustee of the Society for Cardiovascular Angiography and Interventions (SCAI).  For SCAI, he founded the Emerging Leader Mentorship (ELM) Program, an executive leadership track for promising physicians.  A graduate of Brown University for both college and medical school, Dr. Naidu is Past President of the Brown Medical School Board of Directors and current Trustee of the Brown University Corporation.